Not always easy to recognise #FlatEpithelialAtypia, but hope this composite image may help. On ⬅️ columnar cell change (elongated bland nuclei). On ➡️ FEA - smooth contour, >1 layer, low grade round nuclei (like LGDCIS), not perpendicular to basement membrane.
#pathology
🔬 Serous Cystadenoma of the Pancreas: What You Need to Know
Serous Cystadenoma of the Pancreas, also known as Microcystic Serous Adenoma, is a rare benign cystic neoplasm that shows a female predominance (3:1), typically diagnosed around the age of 58. It accounts for about one-third of primary pancreatic cysts.
🧬 In some cases, it may be associated with von Hippel-Lindau (VHL) syndrome, particularly when multifocal.
📍 Anatomical Location:
Most frequently found in the tail of the pancreas, with a body/tail to head/neck ratio of about 1.6:1. In VHL-associated cases, it may involve the entire pancreas.
🔍 Gross Features:
These are usually well-circumscribed lesions, averaging 6 cm in size but ranging from 1 to 30 cm. The most common type is microcystic, with a sponge-like appearance composed of numerous small cysts filled with clear fluid. Other types include:
Oligocystic (Macrocystic): fewer, larger cysts
Solid variant: homogeneous, gelatinous, and yellow-beige in appearance
A classic feature is the presence of a central stellate scar, consisting of hyalinized fibrous tissue. Hemorrhage may occasionally occur. Multifocality is rare but more common in VHL patients.
🔬 Microscopic Findings:
Cysts are lined by cuboidal to low columnar epithelium with clear cytoplasm rich in glycogen (PAS-positive, diastase-sensitive).
Nuclei are round, uniform, with dense chromatin, inconspicuous nucleoli, and no mitoses.
The stroma may range from edematous to fibrous, sometimes myxoid or hyalinized, and features a rich capillary network. Calcifications can be present.
Variants include tiny papillary projections (without fibrovascular cores), oncocytic types with granular cytoplasm, and a solid variant with compact small glands and minimal lumina.
🧪 Immunohistochemistry:
Tumor cells are typically positive for EMA, MUC1, pancytokeratin, inhibin, and GLUT1, and negative for HMB45. These markers help distinguish it from other cystic neoplasms.
🧬 Molecular and Cytogenetics:
VHL gene alterations are common, especially in VHL patients, with loss of heterozygosity on chromosome 3p. Similar findings can occur in sporadic cases, suggesting a genetic component in tumorigenesis.
💧 Cyst Fluid Analysis:
Fluid is typically low-viscosity, with low amylase and CEA (<5–20 ng/mL). Cytology shows cuboidal cells with glycogen-rich cytoplasm. In VHL patients, VHL gene mutations may be detected.
📈 Prognosis:
This neoplasm is almost always benign, with slow growth (median 0.29 cm/year). The malignant transformation risk is <3%, and associated mortality is virtually nonexistent. Large tumors may compress adjacent organs but rarely pose significant clinical concern.
📌 Clinical-Pathologic Summary:
Rare benign cystic neoplasm, mostly in middle-aged women
Preferentially located in the pancreatic tail
Characterized by clear fluid-filled microcysts and central scar
Cuboidal epithelium with glycogen-rich cytoplasm and bland nuclei
Immunopositive for EMA, MUC1, GLUT1
Associated with VHL gene alterations
Excellent prognosis with minimal malignant potential
📚 References:
Pathology Outlines – Serous cystadenoma
StatPearls – Pancreatic Serous Cystadenoma
Am J Surg Pathol 2015;39:1597 (PMID: 26559376)
J Gastrointest Cancer 2010;41:197 (PMID: 20140653)
Pancreatology 2009;9:182 (PMID: 19077470)
Ultrastruct Pathol 2006;30:119 (PMID: 16517478)
World J Surg 2003;27:319 (PMID: 12607059)
Dig Surg 2016;33:240 (PMID: 26998825)
Am J Pathol 2001;158:317 (PMID: 11141506)
📌 Disclaimer: This content is intended for healthcare professionals and is for educational and informational purposes only. It does not replace individualized clinical evaluation, medical judgment, or institutional guidelines. In real-world scenarios, specialist consultation and updated evidence-based protocols are essential.
#SerousCystadenomaOfThePancreas
#MedicalEducation #NotasDePatologia
Case of Fibroadenoma with Myxoid Stroma 🔬
Hypocellular myxoid stroma can give fibroadenoma a strikingly distinctive appearance and can be seen both in sporadically or in association with Carney complex.
#PathX#PathTwitter#breastpath
Colectomy performed for cancer. Colleague's case.
Granulomata present away from cancer. On pictures 1 to 3, hard to be sure what they are, but picture 4 shows a viable schistosoma ovum.
GI schistosomiasis is usually S. mansoni or japonicum.
#GIpath#pathbugs
This is simply an amazing example of lymphatic space invasion "caught in the act" in what appears to be intramucosal (muscularis mucosae invasion) carcinoma in a colorectal polypectomy sample. Of course there might be submucosal invasion that simply is not apparent on the slide.
Other SOX10+ non melanoma cells in sentinel lymph node: salivary gland tissue inclusion. Although common in paraparotid lymph nodes, they have also been described in unusual sites such as the pulmonary hilum (PMID: 21087984) #pathology#dermpath#dermatology#PathX#MedX
A colonic Schwann cell hamartoma, this one forming a nodule. These are generally incidental lesions that arise in adults, described some years ago. #UMiamiPath
Am J Surg Pathol. 2009 May;33(5):781-7. PMID: 19065103.
In thyroid cancer, skeletal muscle invasion represents extrathyroidal spread, but this is only reliable in the lateral lobes and not the isthmus. This is due to Soemmerring's muscle arising from the hyoid bone and inserting on the isthmus. Be careful when assessing tumors here!
Old cases, day 8: esophageal melanocytosis. I’ve only seen this rare finding twice. It may or may not have a relationship with primary esophageal melanoma. https://t.co/7X7vNn0Koc #pathology#gipath#PathTwitter
When your antral reactive gastropathy comes with thrombi...
That's a GAVE!
👯Gastric Antral Vascular Ectasia👯
🍉Watermelon on endoscopy
🩸Causes bleeding
🫘Assoc. with renal, liver and connective tissue/autoimmune diseases.
💁♂️Cd61 great helper!
#GiPath#Pathology